"The 340B Drug Pricing Program Omnibus Guidance – in Two Parts"


Below is an excerpt:

On August 28, 2015 the U.S. Department of Health and Human Services (HHS), published the proposed 340B Drug Pricing Program Omnibus Guidance (Guidance). This article, the first in a two-part series, will provide a guide to the basic framework of the 340B Program and explore how the Guidance manipulates the cornerstones of the Program. Part Two will hone in on items in the Guidance particularly applicable to manufacturers and summarize wins and losses for various stakeholders.

Originally published in Pharmaceutical Compliance Monitor, November 13, 2015

Follow Quarles

Subscribe Media Contact
Back to Main Content

We use cookies to provide you with the best user experience on our website and to analyze statistics related to our website. To understand more about how we use cookies, or for instructions to change your preference and browser settings, please see our Privacy Notice. Please note that if you choose to reject cookies, doing so may impair some of our website's functionality.